97 related articles for article (PubMed ID: 16732600)
1. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers in thyroid cancer diagnostics.
Kato MA; Fahey TJ
Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
[TBL] [Abstract][Full Text] [Related]
4. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
Matesa N; Samija I; Kusić Z
Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
[TBL] [Abstract][Full Text] [Related]
8. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
10. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
11. [Galectin-3 in diagnosis of thyroid cancer].
Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
Whitley RJ; Ain KB
Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of thyroid cancer: state of art.
Boufraqech M; Patel D; Xiong Y; Kebebew E
Expert Opin Med Diagn; 2013 Jul; 7(4):331-42. PubMed ID: 23701167
[TBL] [Abstract][Full Text] [Related]
14. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
Carpi A; Mechanick JI; Saussez S; Nicolini A
J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
[TBL] [Abstract][Full Text] [Related]
15. From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules.
Gasbarri A; Marchetti C; Iervasi G; Bottoni A; Nicolini A; Bartolazzi A; Carpi A
Biomed Pharmacother; 2004; 58(6-7):356-9. PubMed ID: 15271416
[TBL] [Abstract][Full Text] [Related]
16. [RESULTS OF RESEARCH OF GALECTIN-3 AND THYROGLOBULIN IN PATIENTS WITH THYROID NODULES].
Olifirova OS; Knalian SV
Vestn Khir Im I I Grek; 2015; 174(2):81-3. PubMed ID: 26234070
[TBL] [Abstract][Full Text] [Related]
17. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
[TBL] [Abstract][Full Text] [Related]
18. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
19. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence.
Hartl DM; Chami L; Al Ghuzlan A; Leboulleux S; Baudin E; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2602-8. PubMed ID: 19551443
[TBL] [Abstract][Full Text] [Related]
20. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
Layfield LJ; Abrams J; Cochand-Priollet B; Evans D; Gharib H; Greenspan F; Henry M; LiVolsi V; Merino M; Michael CW; Wang H; Wells SA
Diagn Cytopathol; 2008 Jun; 36(6):442-8. PubMed ID: 18478610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
